Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.92 USD | -0.82% | -2.83% | -17.31% |
Apr. 19 | BMO Capital Adjusts Price Target on Incyte to $56 From $64 | MT |
Apr. 01 | Incyte, China Medical System Sign Collaboration, License Agreement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.31% | 11.66B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+56.27% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-11.43% | 11.65B | |
-1.57% | 8.18B | |
+4.08% | 7.78B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Incyte : Study of Squamous Cell Carcinoma of Anal Canal Accepted for Priority Review at FDA